Gareth Griffiths Selected Research

Prednisolone (Predate)

1/2023	Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.
1/2021	Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
1/2020	ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial.
10/2017	ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gareth Griffiths Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 06/2011
22	Infections 03/2023 - 08/2002
11	Tuberculosis (Tuberculoses) 11/2023 - 10/2008
9	COVID-19 09/2023 - 06/2020
7	Adenocarcinoma 07/2023 - 03/2009
7	Breast Neoplasms (Breast Cancer) 10/2020 - 04/2003
6	Fatigue 10/2022 - 04/2013
6	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2013
5	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2017
5	Mesothelioma 11/2023 - 04/2018
5	Disease Progression 10/2022 - 10/2017
5	Hemorrhage 01/2021 - 02/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 06/2013
4	Deglutition Disorders (Dysphagia) 01/2021 - 06/2013
3	Acne Vulgaris 12/2023 - 01/2021
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2019
3	Lung Neoplasms (Lung Cancer) 10/2022 - 02/2016
3	Nausea 10/2022 - 01/2014
3	Malignant Mesothelioma 06/2022 - 01/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 04/2018 - 06/2011
3	Pain (Aches) 11/2014 - 10/2013
2	Asthma (Bronchial Asthma) 04/2024 - 02/2015
2	Headache (Headaches) 01/2023 - 11/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 12/2022
2	Dyspnea (Shortness of Breath) 12/2022 - 10/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 01/2013
2	Cognitive Dysfunction 01/2022 - 11/2020
2	Diarrhea 01/2022 - 01/2021
2	Wounds and Injuries (Trauma) 01/2022 - 01/2002
2	Bronchitis 01/2021 - 01/2019
2	Exanthema (Rash) 01/2021 - 10/2017
2	Venous Thromboembolism 10/2020 - 01/2020
2	Inflammation (Inflammations) 09/2018 - 11/2007
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 03/2009
2	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 08/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015 - 04/2013
2	Esophageal Neoplasms (Esophageal Cancer) 10/2014 - 11/2012

Drug/Important Bio-Agent (IBA)

11	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 11/2010
8	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 06/2011
6	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 08/2002
6	Proteins (Proteins, Gene)FDA Link 07/2020 - 12/2004
5	Capecitabine (Xeloda)FDA Link 07/2023 - 11/2012
5	VaccinesIBA 03/2023 - 12/2005
5	Gemcitabine FDA Link 01/2021 - 04/2013
4	PlatinumIBA 09/2023 - 11/2021
4	Carboplatin (JM8)FDA LinkGeneric 07/2023 - 02/2015
4	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 10/2017
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
4	molnupiravirIBA 01/2023 - 11/2021
4	Cetuximab (Erbitux)FDA Link 11/2017 - 08/2008
3	Spironolactone (Aldactone)FDA LinkGeneric 12/2023 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2023 - 02/2015
3	Rituximab (Mabthera)FDA Link 01/2023 - 11/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2020
3	Bortezomib (Velcade)FDA Link 01/2023 - 01/2018
3	Docetaxel (Taxotere)FDA Link 11/2022 - 10/2017
3	capivasertibIBA 11/2022 - 10/2017
3	NivolumabIBA 09/2022 - 04/2018
3	MetalsIBA 01/2021 - 10/2014
3	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 04/2016
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020 - 02/2016
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 02/2015
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2017 - 07/2013
3	LipidsIBA 01/2017 - 11/2007
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2017
2	Immunoglobulin A (IgA)IBA 12/2023 - 01/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023 - 10/2022
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2023 - 10/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2020
2	guadecitabineIBA 01/2021 - 04/2018
2	MethyltransferasesIBA 01/2021 - 04/2018
2	AsbestosIBA 01/2021 - 04/2018
2	AnticoagulantsIBA 10/2020 - 04/2016
2	acalabrutinibIBA 07/2020 - 01/2020
2	Oxygen (Dioxygen)IBA 07/2020 - 06/2020
2	Eicosapentaenoic AcidIBA 09/2018 - 10/2008
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 03/2009
2	Liposomes (Liposome)IBA 01/2018 - 01/2016
2	Peptides (Polypeptides)IBA 05/2017 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 11/2007
2	Diphosphonates (Bisphosphonates)IBA 01/2014 - 10/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2011 - 08/2002
1	Omalizumab (Xolair)FDA Link 04/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024
1	anti-IgE antibodiesIBA 04/2024
1	niraparibIBA 11/2023

Therapy/Procedure

28	Therapeutics 04/2024 - 09/2007
20	Drug Therapy (Chemotherapy) 09/2023 - 08/2008
11	Radiotherapy 07/2023 - 03/2009
4	Chemoradiotherapy 07/2023 - 03/2009
4	Neoadjuvant Therapy 01/2021 - 06/2011
3	Castration 11/2022 - 10/2017
3	Stents 01/2021 - 10/2014
3	Induction Chemotherapy 01/2017 - 04/2013
2	Immunotherapy 09/2023 - 01/2022
2	Cognitive Training 01/2022 - 11/2020
2	Noninvasive Ventilation 07/2020 - 06/2020
2	Cystectomy 01/2016 - 06/2011
1	Reducing Diet 12/2023